West Pharmaceutical Services, Inc. WST
370.44
(3.16)
(0.85%)
as of 25 Sep
- Market cap
- $26.3B
- P/E
- 47.1×
Follow WST
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
West Pharmaceutical Services, Inc. (WST) Revenue growth
West Pharmaceutical Services, Inc.'s revenue growth over the twelve months to 30 June 2026 was 12.4%, up 6.1 percentage points from fiscal 2025 (6.25%). Over the past ten years it has ranged from −1.92% (fiscal 2024) to 31.9% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Medical Instruments & Supplies industry median of 9.20% and above the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 6.25% | 8.17 |
| FY2024 | −1.92% | (4.10) |
| FY2023 | 2.18% | 0.23 |
| FY2022 | 1.95% | (29.94) |
| FY2021 | 31.9% | 15.20 |
| FY2020 | 16.7% | 9.56 |
| FY2019 | 7.13% | (0.27) |
| FY2018 | 7.40% | 1.44 |
| FY2017 | 5.96% | (1.85) |
| FY2016 | 7.81% | 9.33 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 13.8% | (7.25) |
| Mar 2026 | 21.1% | 13.54 |
| Dec 2025 | 7.51% | (0.22) |
| Sep 2025 | 7.73% | (1.44) |
| 42 more quarters | Free account |
Against its own ten years
Low −1.92%
High 31.9%
Ten-year median
6.25%
Current reading's percentile
55
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| RGEN Repligen Corporation compare | 16.5% |
| BDX Becton, Dickinson and Company compare | 13.1% |
| WST West Pharmaceutical Services, Inc. | 12.4% |
| RMD ResMed Inc. compare | 9.85% |
| ALC Alcon compare | 8.34% |
| BAX Baxter International Inc. compare | 5.36% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| SOLV Solventum Corporation compare | −0.93% |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 9.20% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on WST
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement